KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Borg, J., Phylactides, M., Bartsakoulia, M., Tafrali, C., Lederer, C., Felice, A. E., Papachatzopoulou, A., Kourakli, A., Stavrou, E. F., Christou, S., Hou, J., Karkabouna, S., Lappa-Manakou, C., Ozgur, Z., van Ijcken, W., von Lindern, M., Grosveld, F. G., Georgitsi, M., Kleanthous, M., Philipsen, S., & Patrinos, G. P. Pharmacogenomics, 13(13):1487–1500, October, 2012. Place: England
doi  bibtex   
@article{borg_klf10_2012,
	title = {{KLF10} gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.},
	volume = {13},
	issn = {1744-8042 1462-2416},
	doi = {10.2217/pgs.12.125},
	language = {eng},
	number = {13},
	journal = {Pharmacogenomics},
	author = {Borg, Joseph and Phylactides, Marios and Bartsakoulia, Marina and Tafrali, Christina and Lederer, Carsten and Felice, Alexander E. and Papachatzopoulou, Adamantia and Kourakli, Alexandra and Stavrou, Eleana F. and Christou, Soteroula and Hou, Jun and Karkabouna, Sophia and Lappa-Manakou, Christina and Ozgur, Zeliha and van Ijcken, Wilfred and von Lindern, Marieke and Grosveld, Frank G. and Georgitsi, Marianthi and Kleanthous, Marina and Philipsen, Sjaak and Patrinos, George P.},
	month = oct,
	year = {2012},
	note = {Place: England},
	keywords = {Humans, Polymorphism, Single Nucleotide, Female, Adult, Male, Genetic Markers, Gene Expression, Transcriptome, 3' Untranslated Regions, Heterozygote, Retrospective Studies, Anemia, Sickle Cell/blood/drug therapy/genetics, Antisickling Agents/therapeutic use, beta-Thalassemia/blood/drug therapy/genetics, Early Growth Response Transcription Factors/*genetics, Erythroid Precursor Cells/metabolism, Fetal Hemoglobin/genetics/*metabolism, Hemoglobinopathies/blood/*drug therapy/*genetics, Hydroxyurea/*therapeutic use, Kruppel-Like Transcription Factors/*genetics},
	pages = {1487--1500},
}

Downloads: 0